DNA methylation-mediated Rbpjk suppression protects against fracture nonunion caused by systemic inflammation

Area of Science:

• Skeletal biology
• Inflammation research
• Epigenetics

Background:

• Systemic inflammation complicates skeletal repair, leading to challenges in fracture healing.
• Progenitor cells are key responders to inflammation, but their differentiation is often impaired, resulting in fracture nonunion.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying inflammation-induced impairment of skeletal repair.
• To identify therapeutic targets for restoring bone regeneration in inflammatory conditions.

Main Methods:

• Single-cell RNA sequencing to identify inflammation-responsive cell lineages.
• Genetic animal models (Ikk2ca, Dnmt3b manipulation) to study gene interactions.
• Epigenetic analysis (methylation) and gene ablation (Rbpjk) to validate mechanisms.
• In vivo testing of epigenetically modified progenitor cells for therapeutic efficacy.

Main Results:

• Elevated inflammation upregulates Rbpjk in progenitor cells, hindering differentiation and causing fracture nonunion.
• A novel NF-κB/Dnmt3b/Rbpjk signaling axis mediates inflammation's adverse effects on bone regeneration.
• Dnmt3b deficiency exacerbates fracture repair defects, while its overexpression alleviates them.
• Rbpjk ablation rescues fracture repair in models of inflammation and Dnmt3b loss-of-function.
• Local administration of epigenetically modified progenitor cells restores bone regeneration in an inflammation-mediated fracture nonunion model.

Conclusions:

• The NF-κB/Dnmt3b/Rbpjk axis is a critical regulator of bone regeneration under inflammatory stress.
• Targeting this axis, particularly through epigenetic modification of progenitor cells, offers a promising therapeutic strategy for fracture nonunion.